903 related articles for article (PubMed ID: 15995743)
1. Isomeric [RuCl2(dmso)2(indazole)2] complexes: ruthenium(II)-mediated coupling reaction of acetonitrile with 1H-indazole.
Reisner E; Arion VB; Rufińska A; Chiorescu I; Schmid WF; Keppler BK
Dalton Trans; 2005 Jul; (14):2355-64. PubMed ID: 15995743
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and reactivity of the aquation product of the antitumor complex trans-[Ru(III)Cl4(indazole)2]-.
Cebrián-Losantos B; Reisner E; Kowol CR; Roller A; Shova S; Arion VB; Keppler BK
Inorg Chem; 2008 Jul; 47(14):6513-23. PubMed ID: 18553904
[TBL] [Abstract][Full Text] [Related]
3. Reactions of potent antitumor complex trans-[Ru(III)Cl4(indazole)2]- with a DNA-relevant nucleobase and thioethers: insight into biological action.
Egger A; Arion VB; Reisner E; Cebrián-Losantos B; Shova S; Trettenhahn G; Keppler BK
Inorg Chem; 2005 Jan; 44(1):122-32. PubMed ID: 15627368
[TBL] [Abstract][Full Text] [Related]
4. Tuning of redox potentials for the design of ruthenium anticancer drugs -- an electrochemical study of [trans-RuCl(4)L(DMSO)](-) and [trans-RuCl(4)L(2)](-) complexes, where L = imidazole, 1,2,4-triazole, indazole.
Reisner E; Arion VB; Guedes da Silva MF; Lichtenecker R; Eichinger A; Keppler BK; Kukushkin VY; Pombeiro AJ
Inorg Chem; 2004 Nov; 43(22):7083-93. PubMed ID: 15500346
[TBL] [Abstract][Full Text] [Related]
5. Replacement of chlorides with dicarboxylate ligands in anticancer active Ru(II)-DMSO compounds: a new strategy that might lead to improved activity.
Bratsos I; Serli B; Zangrando E; Katsaros N; Alessio E
Inorg Chem; 2007 Feb; 46(3):975-92. PubMed ID: 17257042
[TBL] [Abstract][Full Text] [Related]
6. Platinum(II)-mediated coupling reactions of acetonitrile with the exocyclic nitrogen of 9-methyladenine and 1-methylcytosine. Synthesis, NMR characterization, and X-ray structures of new azametallacycle complexes.
Longato B; Montagner D; Bandoli G; Zangrando E
Inorg Chem; 2006 Feb; 45(4):1805-14. PubMed ID: 16471997
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, structure, and electrochemical properties of a family of 2-(arylazo)phenolate complexes of ruthenium with unusual C-C coupling and N=N cleavage.
Halder S; Acharyya R; Peng SM; Lee GH; Drew MG; Bhattacharya S
Inorg Chem; 2006 Nov; 45(24):9654-63. PubMed ID: 17112260
[TBL] [Abstract][Full Text] [Related]
8. Study of ruthenium(II) complexes with anticancer drugs as ligands. Design of metal-based phototherapeutic agents.
Cini R; Tamasi G; Defazio S; Corsini M; Zanello P; Messori L; Marcon G; Piccioli F; Orioli P
Inorg Chem; 2003 Dec; 42(24):8038-52. PubMed ID: 14632524
[TBL] [Abstract][Full Text] [Related]
9. Spectroscopic studies and structures of trans-ruthenium(II) and ruthenium(III) bis(cyanide) complexes supported by a tetradentate macrocyclic tertiary amine ligand.
Wong CY; Lee FW; Che CM; Cheng YF; Phillips DL; Zhu N
Inorg Chem; 2008 Nov; 47(22):10308-16. PubMed ID: 18850698
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, structure, and spectroscopic, photochemical, redox, and catalytic properties of ruthenium(II) isomeric complexes containing dimethyl sulfoxide, chloro, and the dinucleating bis(2-pyridyl)pyrazole ligands.
Sens C; Rodríguez M; Romero I; Llobet A; Parella T; Sullivan BP; Benet-Buchholz J
Inorg Chem; 2003 Mar; 42(6):2040-8. PubMed ID: 12639139
[TBL] [Abstract][Full Text] [Related]
11. Coordination of 9-ethylguanine to the mixed-ligand compound alpha-[Ru(azpy)(bpy)Cl2] (azpy = 2-phenylazopyridine and bpy = 2,2'-bipyridine). An unprecedented ligand positional shift, correlated to the cytotoxicity of this type of [RuL2Cl2] (with L = azpy or bpy) complex.
Hotze AC; van der Geer EP; Caspers SE; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
Inorg Chem; 2004 Aug; 43(16):4935-43. PubMed ID: 15285670
[TBL] [Abstract][Full Text] [Related]
12. NO Releasing and Anticancer Properties of Octahedral Ruthenium-Nitrosyl Complexes with Equatorial 1 H-Indazole Ligands.
Orlowska E; Babak MV; Dömötör O; Enyedy EA; Rapta P; Zalibera M; Bučinský L; Malček M; Govind C; Karunakaran V; Farid YCS; McDonnell TE; Luneau D; Schaniel D; Ang WH; Arion VB
Inorg Chem; 2018 Sep; 57(17):10702-10717. PubMed ID: 30106571
[TBL] [Abstract][Full Text] [Related]
13. 1-(2-Picolyl)-substituted 1,2,3-triazole as novel chelating ligand for the preparation of ruthenium complexes with potential anticancer activity.
Bratsos I; Urankar D; Zangrando E; Genova-Kalou P; Košmrlj J; Alessio E; Turel I
Dalton Trans; 2011 May; 40(19):5188-99. PubMed ID: 21465046
[TBL] [Abstract][Full Text] [Related]
14. Bis(acetylacetonato)ruthenium(II) complexes containing alkynyldiphenylphosphines. Formation and redox behaviour of [Ru(acac)2(Ph2PC triple bond CR)2] (R=H, Me, Ph) complexes and the binuclear complex cis-[{Ru(acac)2}2(micro-Ph2PC triple bond CPPh2)}2].
Bennett MA; Byrnes MJ; Willis AC
Dalton Trans; 2007 May; (17):1677-86. PubMed ID: 17443260
[TBL] [Abstract][Full Text] [Related]
15. cis-Tetrachlorido-bis(indazole)osmium(iv) and its osmium(iii) analogues: paving the way towards the cis-isomer of the ruthenium anticancer drugs KP1019 and/or NKP1339.
Büchel GE; Kossatz S; Sadique A; Rapta P; Zalibera M; Bucinsky L; Komorovsky S; Telser J; Eppinger J; Reiner T; Arion VB
Dalton Trans; 2017 Sep; 46(35):11925-11941. PubMed ID: 28850133
[TBL] [Abstract][Full Text] [Related]
16. Crystal structures and DFT calculations of new chlorido-dimethylsulfoxide-M(III) (M = Ir, Ru, Rh) complexes with the N-pyrazolyl pyrimidine donor ligand: kinetic vs. thermodynamic isomers.
Cánaves MM; Cabra MI; Bauzá A; Cañellas P; Sánchez K; Orvay F; García-Raso A; Fiol JJ; Terrón A; Barceló-Oliver M; Ballester P; Mata I; Molins E; Hussain F; Frontera A
Dalton Trans; 2014 May; 43(17):6353-64. PubMed ID: 24599509
[TBL] [Abstract][Full Text] [Related]
17. Dichlorobis(2-phenylazopyridine)ruthenium(II) complexes: characterisation, spectroscopic and structural properties of four isomers.
Velders AH; van der Schilden K; Hotze AC; Reedijk J; Kooijman H; Spek AL
Dalton Trans; 2004 Feb; (3):448-55. PubMed ID: 15252553
[TBL] [Abstract][Full Text] [Related]
18. Consequences of N,C,N'- and C,N,N'-coordination modes on electronic and photophysical properties of cyclometalated aryl ruthenium(II) complexes.
Wadman SH; Lutz M; Tooke DM; Spek AL; Hartl F; Havenith RW; van Klink GP; van Koten G
Inorg Chem; 2009 Mar; 48(5):1887-900. PubMed ID: 19235952
[TBL] [Abstract][Full Text] [Related]
19. Probing ruthenium-acetylide bonding interactions: synthesis, electrochemistry, and spectroscopic studies of acetylide-ruthenium complexes supported by tetradentate macrocyclic amine and diphosphine ligands.
Wong CY; Che CM; Chan MC; Han J; Leung KH; Phillips DL; Wong KY; Zhu N
J Am Chem Soc; 2005 Oct; 127(40):13997-4007. PubMed ID: 16201822
[TBL] [Abstract][Full Text] [Related]
20. Efficient energy conversion in photochromic ruthenium DMSO complexes.
Rachford AA; Petersen JL; Rack JJ
Inorg Chem; 2006 Jul; 45(15):5953-60. PubMed ID: 16842000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
